Are Indian generic medicines safe to use?

Indian-manufactured generics supply a very large share of the world's medicine volume, including a substantial proportion of the generic prescriptions dispensed in the United States and Europe. Many patients in Western countries already take Indian-made medicine without knowing it, because the manufacturer's name rarely appears on the pharmacy label.

So the question is not really 'is Indian medicine safe'. It is 'is this specific manufacturer, making this specific product, operating to a standard I can verify'. That is a question with a concrete answer.

A generic is not a loose imitation. To be approved in a regulated market it must contain the same active ingredient at the same strength, in the same dosage form, taken by the same route — and it must demonstrate bioequivalence.

Bioequivalence means the amount of drug reaching the bloodstream, and the speed at which it gets there, must fall within a narrow statistical range of the reference product. This is measured in human studies, not assumed.

The EMA applies an equivalent framework across the European Union. The identity of the molecule is not in question; what regulators police is whether a given factory reliably produces it to specification, batch after batch.

It would be dishonest to claim there is no risk. There are three genuine concerns, and none of them is 'the molecule is different'.

• Manufacturer variability. India has thousands of manufacturers ranging from globally inspected export facilities to small domestic producers. The spread in quality systems is wide.
• Counterfeit and diverted product in unregulated distribution channels. This is a supply-chain problem, not a manufacturing problem, and it exists in every country.
• Narrow-therapeutic-index drugs. For molecules such as warfarin, tacrolimus, lithium, levothyroxine and antiepileptics, small variations in absorption matter clinically. These require monitoring after any brand change, regardless of origin.

This is the part most articles skip. Verification is practical and takes a few minutes.

1. 1Identify the manufacturer by name, not just the salt or the seller.
2. 2Check whether that manufacturer appears in the WHO prequalification register or holds approvals for regulated export markets.
3. 3Confirm the active salt and strength on the pack match your prescription character for character.
4. 4Record batch number, manufacturing date and expiry date, and keep the carton.
5. 5Compare the physical product against a reference description — tablet markings, colour, packaging quality, print quality.
6. 6After switching, track your own clinical markers: blood pressure, glucose, INR, symptom scores — whatever applies to your condition.

A generic from a WHO-prequalified or FDA/EMA-inspected Indian facility, containing the same salt at the same strength, purchased through a channel that requires a prescription and discloses batch details, is a reasonable clinical option for most off-patent molecules — with your physician's agreement.

A product of unknown manufacture, bought from a seller who does not ask for a prescription and will not disclose batch information, is not a reasonable option at any price, wherever in the world it was made.